Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Nobilis Health Corp. NRTSF OTC

Other OTC • Healthcare • Medical - Care Facilities • CA • USD

SharesGrow Score
42/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Nobilis Health Corp. (NRTSF) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 38/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

Analyst outlook: 1 / 2 analysts rate NRTSF as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth ?/100 (Fail), Past 0/100 (Fail), Health 100/100 (Fail), Moat 28/100 (Fail), Future 40/100 (Partial), Income ?/100 (Fail).

NRTSF SharesGrow Score Overview

56/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 0/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 40/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NRTSF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
—
GROWTH N/A
N/A
No analyst coverage available for this stock.
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
100/100
Balance sheet NRTSF: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
NRTSF: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
40/100
Analyst outlook: 1 / 2 analysts rate NRTSF as buy (50%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume657
Avg Volume (30D)45.9K
Market Cap$78.00
Beta (1Y)-328.99
Share Statistics
IPO Date2011-11-07
Employees700
CEOPatrick Yoder
Financial Highlights & Ratios
Analyst Forecast
Rating ConsensusBuy
Analysts Covering2
Buy 50% Hold 50% Sell 0%
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA65500B1031

Price Chart

Track all markets on TradingView
NRTSF
Nobilis Health Corp.  ·  Other OTC
Healthcare • Medical - Care Facilities
0.00 52WK RANGE 0.00

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message